SelectIQ Analysis
What is SelectIQ?
SelectIQ specializes in automating referral networks for clinical trial sites. Their platform reduces the burden on trial sites and referring providers by streamlining patient identification and enrollment processes. This approach minimizes screening failures and enhances referral volume, ultimately improving patient enrollment predictions.
Location
New York City, United States
Employees
1-10
Founded
2022
Company Stage
Seed
Investors
- Lombardstreet Ventures
- Palumni VC
- Y Combinator
YC Batch
W23
Product Features & Capabilities
- Patient Identification Service, Rapid Feasibility Tool, automates referral network for clinical trials, reduces provider burden, enhances patient identification using EHR data, predicts enrollment accurately, pre-screens patients automatically, leverages physician networks.
Who are the founders of SelectIQ
JM
Jason Marmon
Co-founder & CTO
Market Focus
SelectIQ primarily focuses on the healthcare industry, specifically in the area of clinical trials and provider activation through automation of referral networks and patient identification using EHR data.
Competitors Overview
SelectIQ operates in the clinical trial recruitment automation market, where it faces competition from several notable companies:
-
Antidote: This digital platform simplifies patient connections to clinical trials through user-friendly technology and partnerships with health information websites and advocacy groups. Antidote's streamlined enrollment process enhances patient engagement, making it easier for patients to find relevant trials.
-
AutoCruitment: Specializing in automating patient recruitment, AutoCruitment uses targeted digital advertising campaigns and advanced algorithms to efficiently engage participants. This focus on automation can lead to faster recruitment times.
-
CitrusLabs: Offers customized patient recruitment solutions that leverage advanced technology and data analytics. Their patient-centric model aims to maximize engagement and retention, which is crucial for successful trial outcomes.
-
Clinical Trial Media: Known for innovative multi-channel advertising campaigns that blend traditional media with digital platforms, Clinical Trial Media emphasizes storytelling to build trust with potential participants, which can enhance recruitment efforts.
-
IQVIA: A global leader in clinical trials, IQVIA utilizes deep data analytics and AI to optimize recruitment strategies, particularly in complex therapeutic areas. Their extensive resources and expertise provide a competitive edge in the market.
Notable differences or advantages of these competitors include their unique approaches to patient engagement, automation, and the use of advanced technology to streamline recruitment processes. For instance, Patiro, mentioned in the source, emphasizes a patient-centric approach that not only focuses on efficient enrollment but also on ongoing support for retention, resulting in significant reductions in dropout rates and faster recruitment timelines.
See something that needs updating? Suggest edits to this profile.